EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer

Thomas John, Hiroaki Akamatsu, Angelo Delmonte, Wu Chou Su, Jong Seok Lee, Gee Chen Chang, Xiangning Huang, Suzanne Jenkins, Yi Long Wu

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)

Fingerprint

Dive into the research topics of 'EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences